Tongrentang's Subsidiary Secures Hong Kong Registration for Traditional Chinese Medicine Product

Stock News
05/26

Beijing Tong Ren Tang Co.,Ltd. (600085.SH) has announced that its controlled subsidiary, TONGRENTANGCM, has obtained a Certificate of Registration for Proprietary Chinese Medicine from the Chinese Medicine Council of Hong Kong. This certificate authorizes the sale of "Antelope Horn Powder Capsules [Tongrentang]" in the Hong Kong Special Administrative Region of the People's Republic of China.

Following the receipt of this registration certificate, TONGRENTANGCM's Antelope Horn Powder Capsules [Tongrentang] are now permitted for sale in Hong Kong. This development is expected to help diversify the company's product portfolio and support its market expansion efforts. The acquisition of this registration is not anticipated to have a significant immediate impact on the company's production operations or financial performance.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10